SRS230 - Development and validation of the NOVA score for surgical triage in metastatic spinal cord compression

View at publisher Summarise with VIRAT
Authors: Elie Najjar, Shahbaz Khan, Rawan Masarwa, Rodrigo Muscogliati, Opinder Sahota, Khalid M. I. Salem, Nasir Quaraishi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Study Design Retrospective diagnostic model development and validation study. Objectives To develop and validate the NOVA Score, a pragmatic, surgeon-oriented tool for predicting 12-month survival in patients with metastatic spinal cord compression (MSCC), and to compare its performance to established prognostic scores and oncologist estimates. Methods Two independent cohorts of patients with MSCC referred for surgical consideration were included from a tertiary spine center: a derivation cohort (n = 184) and a validation cohort (n = 100). Feature selection was performed using random forest analysis, multivariable logistic regression, and permutation-based variable importance. The final NOVA Score incorporated three clinical parameters: Karnofsky Performance Status (KPS), primary tumor category, and presence of extraspinal metastases. The score ranges from 0–10, with a threshold of ≥7 used to predict >12-month survival. Predictive performance was assessed using accuracy, F1-score, area under the receiver operating characteristic curve (AUC), Cohen’s kappa, and calibration plots. Results In the validation cohort, the NOVA Score achieved an accuracy of 71.0%, AUC of 0.693, F1-score of 47.3% for >12-month survival, and Cohen’s kappa of 0.28. Calibration plots showed good agreement in the mid-to-high probability range. Compared to the Revised Tokuhashi Score, OSRI, Modified Bauer Score, and oncologist estimates, NOVA demonstrated superior sensitivity for identifying long-term survivors using only three readily available variables. Conclusions The NOVA Score is a simple, reproducible tool for early prognostication in MSCC. Its minimal input requirements and balanced performance support its utility for surgical triage in multidisciplinary settings. Further external validation is warranted.

Fields of Study & Subjects

Management of metastatic bone disease Spinal Fractures and Fixation Techniques Cervical and Thoracic Myelopathy

Publication details

Journal / source
British journal of surgery
Volume
113
Issue
Supplement_2
Publication date
1 March 2026
Language
EN